We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
21/5/2018 14:48 | Thanks for the advice | landy90 | |
21/5/2018 14:12 | Live link: Landy, just replace one of the letters in http with a capital and this avoids the ADVFN hxxp anti-link syndrome! | bones | |
21/5/2018 14:10 | hxxps://www.cryolife Cryolife recently purchased a graft business not dissimilar to what AORTECH are creating. | landy90 | |
21/5/2018 13:46 | I think this nails it really. "A huge amount of effort has gone into this announcement. The level of detail really gives a feel for future potential. Patches and grafts could be worth £50m plus and the HV is 250m in surgical and the same again if leaflets taken into TAVI. Dedicated teams to develop, manufactured and take to market. No requirement to establish infrastructure it all comes via RUA, VFT Compliance Solutions and distributors which McKenna will set up." A possible potential £550m of value (from £2.4m of additional investment catalysing the £60m existing invested capital to date) and leveraging off some pretty unique corporate relationships and know how developed over 20 years of being in this sector You are looking at an Option here with a value in binary terms of £0 or £550m I don't think a value of c.£5.5m or 1% of potential terminal value does real justice to the risk-reward and future volatility potential Massive mispriced optionality available right here right now. Do not expect it to last long at this level. | the stigologist | |
21/5/2018 13:46 | Once we get some PR out there and Bill lives up to his promise we won't be here for long | turbotrader2 | |
21/5/2018 13:26 | Turbo, you took the words out of my mouth. As Stig has so eloquently highlighted, the financial future is commercially very rewarding. | k1ngkonggb | |
21/5/2018 13:21 | i.e. your usual suspect mug punter sees a '30% discount' placing what they don't see because they are financially illiterate is existing holders get a bonus element so at 40 odd we're unchanged on the day £2.4m of investment to unlock £60m of sunk cost investment that could deliver a return of many multiples of £60m | the stigologist | |
21/5/2018 13:15 | Because they are thick? | turbotrader2 | |
21/5/2018 12:22 | Why are some people selling at 37p ?? | bones | |
21/5/2018 12:21 | Live link: | bones | |
21/5/2018 12:03 | hxxp://www.coherentc | landy90 | |
21/5/2018 11:54 | A huge amount of effort has gone into this announcement. The level of detail really gives a feel for future potential. Patches and grafts could be worth £50m plus and the HV is 250m in surgical and the same again if leaflets taken into TAVI. Dedicated teams to develop, manufactured and take to market. No requirement to establish infrastructure it all comes via RUA, VFT Compliance Solutions and distributors which McKenna will set up. | landy90 | |
21/5/2018 11:36 | In the 3 for 10 open offer | landy90 | |
21/5/2018 11:34 | How would I get my hands on the discounted shares considering I am an existing holder? | meemmeem | |
21/5/2018 10:56 | This will gather momentum as new people see the RNS, then find there are no shares in the market place to fulfil the demand. | bones | |
21/5/2018 10:38 | It looks to be a professional way forward. These placing shares have not been forward sold or flipped already as the volume hasn't been there to do so. Sticky holders for sureBig things in the works here.Blue finish? | mikeh30 | |
21/5/2018 10:30 | Stig, Totally agree. Just looking forward to getting my hands on some of the placing shares. | k1ngkonggb | |
21/5/2018 10:25 | Expecting 50p+ finish and 350p+ within weeks/months based on £50m as a starting point market cap | the stigologist | |
21/5/2018 09:54 | "The net proceeds of the Placing and the Subscription, along with those funds raised pursuant to the Open Offer, will be used over a two year period to fund the development of textile substrate products (patches and grafts); stage one of heart valve development; investment in capital equipment for heart valve manufacturing and testing and for general working capital purposes" | euclid5 | |
21/5/2018 09:49 | In 2014, the cardiovascular and soft tissue repair patches market was valued at $2.5 billion and estimated to reach nearly $5.8 billion by 2021 Big markets | mikeh30 | |
21/5/2018 09:29 | if you held 100,000 shares prior to today they'd have been worth 44k today you have 100,000 shares + rights over 30,000 at 30p so theoretically at c.41p we're at breakeven for the day due to the bonus element from our rights i think given the news we really should be 50-60p but markets are never very efficient for such small caps, but the trend is now up and should be significantly up going forward the realisation that we have Ely+Berg + £60m of invested capital in IP development could mean at some point the market wakes up pretty suddenly that this really should be valued c.60m+ | the stigologist | |
21/5/2018 09:13 | Would expect Stockdale to publish at some point, | landy90 | |
21/5/2018 09:08 | Wonder if we will get a broker view or some PR Surrounding the prospects and board appointments? | turbotrader2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions